v3.25.2
Segment information - Information by Segment on Current Cost of Supplies Basis (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Disclosure of operating segments [line items]      
Revenue $ 284,312 $ 316,620 $ 381,314
Share of profit/(loss) of joint ventures and associates (CCS basis) 2,967 3,758 3,930
Interest and other income, of which: 1,724 2,838 915
Interest income 2,372 2,313 1,046
Net (losses)/gains on sale and revaluation of non-current assets and businesses (288) 257 642
Other (360) 268 (773)
Total expenditure 259,107 290,556 321,386
Production and manufacturing expenses 23,379 25,240 25,518
Selling, distribution and administrative expenses 12,439 13,433 12,883
Research and development expenses 1,099 1,287 1,075
Exploration expenses 2,411 1,750 1,712
Depreciation, depletion and amortisation charge, of which: 26,872 31,290 18,529
Impairment losses 4,502 8,947 2,313
Impairment reversals (333) (762) (6,177)
Interest expense 4,787 4,673 3,181
Taxation charge/(credit) (CCS basis) 13,492 13,194 21,497
Impairment losses on property, plant and equipment 3,673 8,182 1,799
Goodwill 510 635 361
Intangible assets other than goodwill 319 130 153
Reversal of impairment loss recognised in profit or loss, property, plant and equipment 333 627 6,177
Intangible assets other than goodwill 0 135 0
CCS earnings      
Disclosure of operating segments [line items]      
Taxation charge/(credit) (CCS basis) 91 203 (444)
CCS earnings 16,792 20,281 41,562
Inter-segment      
Disclosure of operating segments [line items]      
Revenue 96,944 105,612 132,682
Operating segments      
Disclosure of operating segments [line items]      
Third-party and inter-segment purchases (CCS basis) 284,676 317,680 392,884
Total expenditure 36,917 39,960 39,476
Production and manufacturing expenses 23,379 25,240 25,518
Selling, distribution and administrative expenses 12,439 13,433 12,883
Research and development expenses 1,099 1,287 1,075
Exploration expenses 2,411 1,750 1,712
Depreciation, depletion and amortisation charge, of which: 26,872 31,290 18,529
Impairment losses 4,502 8,947 2,313
Impairment reversals (333) (762) (6,177)
Interest expense 4,787 4,673 3,181
Integrated Gas      
Disclosure of operating segments [line items]      
Revenue 37,290 37,645 54,751
Share of profit/(loss) of joint ventures and associates (CCS basis) 1,931 1,951 1,219
Interest and other income, of which: 48 137 (714)
Interest income 8 6 43
Net (losses)/gains on sale and revaluation of non-current assets and businesses (100) (22) 101
Other 140 153 (858)
Taxation charge/(credit) (CCS basis) 3,144 2,806 5,901
Reversal of impairment loss recognised in profit or loss, property, plant and equipment   325 3,449
Integrated Gas | CCS earnings      
Disclosure of operating segments [line items]      
CCS earnings 9,590 7,057 22,221
Integrated Gas | Inter-segment      
Disclosure of operating segments [line items]      
Revenue 8,715 11,560 18,412
Integrated Gas | Operating segments      
Disclosure of operating segments [line items]      
Third-party and inter-segment purchases (CCS basis) 24,055 27,356 37,785
Total expenditure 4,442 4,809 5,226
Production and manufacturing expenses 4,153 4,529 4,907
Selling, distribution and administrative expenses 164 154 207
Research and development expenses 125 126 112
Exploration expenses 414 216 240
Depreciation, depletion and amortisation charge, of which: 6,150 8,903 2,211
Impairment losses 564 3,472 115
Impairment reversals (9) (324) (3,449)
Interest expense 189 146 84
Upstream      
Disclosure of operating segments [line items]      
Revenue 6,606 6,475 8,352
Share of profit/(loss) of joint ventures and associates (CCS basis) 1,189 768 2,111
Interest and other income, of which: 609 671 726
Interest income 18 27 22
Net (losses)/gains on sale and revaluation of non-current assets and businesses 89 209 437
Other 502 435 267
Taxation charge/(credit) (CCS basis) 9,387 8,380 14,078
Impairment losses on property, plant and equipment     320
Reversal of impairment loss recognised in profit or loss, property, plant and equipment   203 2,504
Upstream | CCS earnings      
Disclosure of operating segments [line items]      
CCS earnings 7,772 8,540 16,258
Upstream | Inter-segment      
Disclosure of operating segments [line items]      
Revenue 39,939 41,230 52,285
Upstream | Operating segments      
Disclosure of operating segments [line items]      
Third-party and inter-segment purchases (CCS basis) 7,368 7,890 10,666
Total expenditure 9,790 9,830 10,321
Production and manufacturing expenses 9,351 9,186 9,676
Selling, distribution and administrative expenses 176 326 327
Research and development expenses 263 318 318
Exploration expenses 1,997 1,534 1,472
Depreciation, depletion and amortisation charge, of which: 11,223 12,463 10,334
Impairment losses 327 1,360 950
Impairment reversals (75) (206) (2,504)
Interest expense 806 507 345
Marketing      
Disclosure of operating segments [line items]      
Revenue 120,089 130,559 149,439
Share of profit/(loss) of joint ventures and associates (CCS basis) 6 561 249
Interest and other income, of which: (432) 73 (82)
Interest income 1 9 0
Net (losses)/gains on sale and revaluation of non-current assets and businesses (399) 1 (169)
Other (34) 63 87
Taxation charge/(credit) (CCS basis) 894 851 918
Marketing | CCS earnings      
Disclosure of operating segments [line items]      
CCS earnings 1,894 3,057 2,292
Marketing | CCS earnings | Revision of prior period, reclassification, adjustment      
Disclosure of operating segments [line items]      
CCS earnings   104 158
Marketing | Inter-segment      
Disclosure of operating segments [line items]      
Revenue 4,938 5,299 6,195
Marketing | Operating segments      
Disclosure of operating segments [line items]      
Third-party and inter-segment purchases (CCS basis) 107,210 118,912 140,368
Total expenditure 10,681 11,142 10,149
Production and manufacturing expenses 1,322 1,463 1,293
Selling, distribution and administrative expenses 9,150 9,427 8,631
Research and development expenses 209 252 225
Exploration expenses 0 0 0
Depreciation, depletion and amortisation charge, of which: 3,866 2,477 2,027
Impairment losses 1,633 430 479
Impairment reversals (1) (1) (151)
Interest expense 56 53 47
Chemicals and Products      
Disclosure of operating segments [line items]      
Revenue 90,918 97,080 115,541
Share of profit/(loss) of joint ventures and associates (CCS basis) 648 577 362
Interest and other income, of which: 121 64 222
Interest income 79 57 24
Net (losses)/gains on sale and revaluation of non-current assets and businesses 6 (46) 265
Other 36 53 (67)
Taxation charge/(credit) (CCS basis) 177 (210) 928
Impairment losses on property, plant and equipment     257
Reversal of impairment loss recognised in profit or loss, property, plant and equipment 114    
Chemicals and Products | CCS earnings      
Disclosure of operating segments [line items]      
CCS earnings 1,757 1,482 4,380
Chemicals and Products | CCS earnings | Revision of prior period, reclassification, adjustment      
Disclosure of operating segments [line items]      
CCS earnings   (104) (158)
Chemicals and Products | Inter-segment      
Disclosure of operating segments [line items]      
Revenue 38,381 42,816 48,999
Chemicals and Products | Operating segments      
Disclosure of operating segments [line items]      
Third-party and inter-segment purchases (CCS basis) 114,972 123,337 147,069
Total expenditure 8,392 9,598 9,564
Production and manufacturing expenses 6,605 7,394 7,100
Selling, distribution and administrative expenses 1,636 2,022 2,303
Research and development expenses 151 182 161
Exploration expenses 0 0 0
Depreciation, depletion and amortisation charge, of which: 4,700 6,269 3,162
Impairment losses 1,319 2,777 357
Impairment reversals (114) (90) (73)
Interest expense 70 61 21
Renewables and Energy Solutions      
Disclosure of operating segments [line items]      
Revenue 29,366 44,819 53,190
Share of profit/(loss) of joint ventures and associates (CCS basis) (807) (96) (7)
Interest and other income, of which: 242 75 57
Interest income 2 12 (2)
Net (losses)/gains on sale and revaluation of non-current assets and businesses 119 110 8
Other 121 (47) 51
Taxation charge/(credit) (CCS basis) 99 1,320 (292)
Reversal of impairment loss recognised in profit or loss, property, plant and equipment 134    
Renewables and Energy Solutions | CCS earnings      
Disclosure of operating segments [line items]      
CCS earnings (1,229) 3,089 (1,027)
Renewables and Energy Solutions | Inter-segment      
Disclosure of operating segments [line items]      
Revenue 4,971 4,707 6,791
Renewables and Energy Solutions | Operating segments      
Disclosure of operating segments [line items]      
Third-party and inter-segment purchases (CCS basis) 31,074 40,170 57,024
Total expenditure 2,915 3,763 3,547
Production and manufacturing expenses 1,934 2,610 2,520
Selling, distribution and administrative expenses 887 1,058 972
Research and development expenses 94 95 55
Exploration expenses 0 0 0
Depreciation, depletion and amortisation charge, of which: 907 1,159 777
Impairment losses 658 908 412
Impairment reversals (134) (141) 0
Interest expense 6 4 2
Corporate      
Disclosure of operating segments [line items]      
Revenue 43 42 41
Share of profit/(loss) of joint ventures and associates (CCS basis) 0 (3) (4)
Interest and other income, of which: 1,136 1,818 706
Interest income 2,264 2,202 959
Net (losses)/gains on sale and revaluation of non-current assets and businesses (3) 5 0
Other (1,125) (389) (253)
Taxation charge/(credit) (CCS basis) (209) 47 (36)
Corporate | CCS earnings      
Disclosure of operating segments [line items]      
CCS earnings (2,992) (2,944) (2,562)
Corporate | Inter-segment      
Disclosure of operating segments [line items]      
Revenue 0 0 0
Corporate | Operating segments      
Disclosure of operating segments [line items]      
Third-party and inter-segment purchases (CCS basis) (3) 15 (28)
Total expenditure 697 818 669
Production and manufacturing expenses 14 58 22
Selling, distribution and administrative expenses 426 446 443
Research and development expenses 257 314 204
Exploration expenses 0 0 0
Depreciation, depletion and amortisation charge, of which: 26 19 18
Impairment losses 1 0 0
Impairment reversals 0 0 0
Interest expense $ 3,660 3,902 2,682
Corporate1 | CCS earnings | Revision of prior period, reclassification, adjustment      
Disclosure of operating segments [line items]      
CCS earnings   $ 133 $ 101